Journal
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY
Volume 2, Issue 5, Pages 753-777Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1517/17425255.2.5.753
Keywords
drug resistance; glutathione conjugates; lung cancer; radiation; RALBP1; RLIP76; transport
Funding
- NCI NIH HHS [CA-104661, CA-77495] Funding Source: Medline
Ask authors/readers for more resources
Despite considerable progress over the last 25 years in the systemic therapy of lung cancer, intrinsic and acquired resistance to chemotherapeutic agents and radiation remains a vexing problem. The number of mechanisms of therapeutic resistance in lung cancer has expanded considerably over the past three decades, and the crucial role of stress resistance pathways is increasingly recognised as a cause of intrinsic and acquired chemo- and radiotherapy resistance. This paper reviews recent evidence for stress defence proteins, particularly RALBP1/RLIP76, in mediating intrinsic and acquired chemotherapy and radiation resistance in human lung cancer.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available